Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Drugs|April 24, 2003
[The kidney as a target organ in diabetic patients with arterial hypertension]Giancarlo VibertiJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|May 29, 2003
The need for tighter control of cardiovascular risk factors in diabetic patientsGiancarlo VibertiJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 22, 2003
Regression of albuminuria: latest evidence for a new approachGiancarlo VibertiJournal of Diabetes and Its Complications|May 4, 2005
Thiazolidinediones-benefits on microvascular complications of type 2 diabetesGiancarlo VibertiAmerican Journal of Hypertension|October 16, 2004
Microalbuminuria and cardiovascular riskJanaka Karalliedde, Giancarlo VibertiJournal of the American Society of Nephrology : JASN|November 6, 2010
Proteinuria in diabetes: bystander or pathway to cardiorenal disease?Janaka Karalliedde, Giancarlo VibertiNature Reviews. Nephrology|January 21, 2015
Diabetes. Excess mortality in well-controlled T1DM without renal diseaseJanaka Karalliedde, Giancarlo VibertiCirculation|August 7, 2002
Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effectGiancarlo Viberti, Nigel M Wheeldon, Journal of Diabetes and Its Complications|December 13, 2002
Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targetsJorge Plutzky, Giancarlo Viberti, Steven HaffnerJournal of the American Society of Nephrology : JASN|July 20, 2007
Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolismLuigi Gnudi, Stephen M Thomas, Giancarlo VibertiPageof 6